What are the Benefits of Tezacaftor in Pediatric Patients?
The primary benefit of tezacaftor in pediatric patients is the improvement in lung function. Clinical trials have shown that tezacaftor, in combination with ivacaftor, can lead to significant improvements in FEV1 (Forced Expiratory Volume in one second), a measure of lung function. Additionally, patients often experience fewer pulmonary exacerbations and improved quality of life.
